Ligand validation:5U7O

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5U7O designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5U7O_NAG_B_704	100%	88%	0.024	0.989	0.23	0.44	-	-	0	0	100%	0.9333
5U7O_NAG_G_611	100%	89%	0.032	0.992	0.19	0.44	-	-	0	0	100%	0.9333
5U7O_NAG_B_702	100%	88%	0.035	0.991	0.22	0.44	-	-	0	0	100%	0.9333
5U7O_NAG_H_301	100%	88%	0.032	0.981	0.23	0.42	-	-	0	0	100%	0.9333
5U7O_NAG_G_633	100%	79%	0.033	0.979	0.25	0.6	-	-	0	0	100%	0.9333
5U7O_NAG_G_658	100%	89%	0.04	0.982	0.21	0.41	-	-	0	0	100%	0.9333
5U7O_NAG_B_703	99%	90%	0.044	0.981	0.21	0.4	-	-	1	0	100%	0.9333
5U7O_NAG_G_648	99%	90%	0.044	0.975	0.19	0.42	-	-	0	0	100%	0.9333
5FYL_NAG_G_1582	97%	55%	0.046	0.958	0.73	0.99	1	1	0	0	100%	0.9333
6MU8_NAG_G_634	84%	79%	0.083	0.943	0.24	0.62	-	1	0	0	100%	0.9333
6MU7_NAG_G_634	83%	84%	0.081	0.94	0.24	0.52	-	-	0	0	100%	0.9333
6MTN_NAG_G_634	83%	74%	0.09	0.947	0.35	0.66	-	1	0	0	100%	0.9333
6NNF_NAG_G_638	81%	89%	0.124	0.976	0.2	0.44	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.